Insufficient scRNA-seq data for expression of DEFA3 at single-cell level.
Insufficient scRNA-seq data for expression of DEFA3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| spleen | 90% | 4654.91 | 217 / 241 | 0% | 0 | 0 / 0 |
| lung | 81% | 1384.78 | 470 / 578 | 4% | 0.14 | 51 / 1155 |
| peripheral blood | 79% | 22394.33 | 733 / 929 | 0% | 0 | 0 / 0 |
| liver | 40% | 111.00 | 90 / 226 | 2% | 0.15 | 8 / 406 |
| thymus | 23% | 30.77 | 148 / 653 | 8% | 0.51 | 48 / 605 |
| heart | 27% | 62.37 | 234 / 861 | 0% | 0 | 0 / 0 |
| kidney | 19% | 17.62 | 17 / 89 | 8% | 0.39 | 70 / 901 |
| adipose | 26% | 50.52 | 311 / 1204 | 0% | 0 | 0 / 0 |
| brain | 13% | 16.06 | 353 / 2642 | 10% | 0.61 | 68 / 705 |
| breast | 20% | 32.26 | 93 / 459 | 1% | 0.04 | 14 / 1118 |
| muscle | 13% | 16.83 | 108 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 3.91 | 12 / 258 | 8% | 1.53 | 19 / 230 |
| uterus | 9% | 11.16 | 16 / 170 | 3% | 0.05 | 12 / 459 |
| blood vessel | 10% | 17.41 | 132 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 7% | 5.93 | 13 / 180 | 1% | 0.01 | 4 / 430 |
| stomach | 4% | 7.00 | 14 / 359 | 4% | 0.07 | 12 / 286 |
| esophagus | 5% | 7.87 | 71 / 1445 | 2% | 0.04 | 4 / 183 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.25 | 2 / 29 |
| bladder | 5% | 2.86 | 1 / 21 | 2% | 0.04 | 8 / 504 |
| intestine | 3% | 4.35 | 32 / 966 | 2% | 0.03 | 10 / 527 |
| pancreas | 2% | 3.02 | 5 / 328 | 3% | 0.08 | 6 / 178 |
| skin | 2% | 2.08 | 44 / 1809 | 1% | 0.04 | 4 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| prostate | 2% | 0.91 | 4 / 245 | 0% | 0.01 | 2 / 502 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0050829 | Biological process | defense response to Gram-negative bacterium |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_0051607 | Biological process | defense response to virus |
| GO_0051673 | Biological process | disruption of plasma membrane integrity in another organism |
| GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO_0031640 | Biological process | killing of cells of another organism |
| GO_0002227 | Biological process | innate immune response in mucosa |
| GO_0050832 | Biological process | defense response to fungus |
| GO_0050830 | Biological process | defense response to Gram-positive bacterium |
| GO_0030520 | Biological process | estrogen receptor signaling pathway |
| GO_0019731 | Biological process | antibacterial humoral response |
| GO_0035578 | Cellular component | azurophil granule lumen |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | DEFA3 |
| Protein name | Defensin, alpha 3, neutrophil-specific Neutrophil defensin 3 (Defensin, alpha 3) (HNP-3) (HP-3) (HP3) [Cleaved into: HP 3-56; Neutrophil defensin 2 (HNP-2) (HP-2) (HP2)] |
| Synonyms | DEF3 |
| Description | FUNCTION: Effector molecule of the innate immune system that acts via antibiotic-like properties against a broad array of infectious agents including bacteria, fungi, and viruses . Possesses the ability to neutralize bacterial toxins such as B. anthracis lethal factor, Clostridium difficile cytotoxin B as well as leukocidin produced by Staphylococcus aureus . Blocks also herpes simplex virus infection by interacting with envelope glycoprotein B and thus preventing its binding to heparan sulfate, the receptor for attachment . . |
| Accessions | Q6EZE9 P59666 ENST00000327857.7 |